Table 1 Clinical findings and detected repeat expansions in families undergoing exome sequencing.

From: Diagnostic uplift through the implementation of short tandem repeat analysis using exome sequencing

STR disorder (Gene)

Family

Individual

Sex

Age at evaluation

Clinical findings

EH result

Validation method

Validation result

DRPLA (ATN1)

F1

Father

M

52

Ataxia with chorea

22/62

fragment analysis

19/64

Proband

M

14

DD with regression, epilepsy

21/48

fragment analysis

18/89

F2

Father

M

44

Gait abnormality

23/61

fragment analysis

20/61

Proband

F

10

DD with regression, epilepsy

21/60

fragment analysis

18/78

F3

Father

M

51

Mild cognitive decline

25/53

fragment analysis

22/58

Proband

M

15

DD, epilepsy, microcephaly, ataxia, involuntary movement

19/63

fragment analysis

16/70

SCA7 (ATXN7)

F4

Mother

F

55

Cerebellar ataxia with foveal atrophy

10/47

fragment analysis;

Nanopore

10/41;

9/42

Proband

F

29

Cerebellar ataxia with foveal atrophy

10/47

fragment analysis;

Nanopore

10/41;

6/47

F5

Father

M

38

Asymptomatic

10/42

fragment analysis

10/42

Proband

M

6

DD with regression, diffuse cerebellar atrophy

10/36

fragment analysis

10/92

DM1 (DMPK)

F6

Mother

F

35

Myotonia of tongue and grip

13/62

Southern blotting

13/617

Proband

M

5

DD, hypotonia, elevated CK levels, myopia

43/64

Southern blotting

5/1171

F7

Father

M

55

Asymptomatic (pre-mutation)

13/44

fragment analysis

NA

Proband

M

22

Foot deformity, neck webbing, myopathic electromyography

26/51

fragment analysis

26/57

  1. EH ExpansionHunter, M male, F female, DD developmental delay, CK creatinine kinase, DRPLA dentatorubral-pallidoluysian atrophy, SCA7 spinocerebellar ataxia type 7, DM1 myotonic dystrophy type 1, NA not applicable.